Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: SAGENT PHARMACEUTICALS, INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2022-09-26 to 2024-09-30
Current total value of award: $47750653.44
Description: CIPROFLOXACIN 5% DEXTROSE, INJECTION, 400MG/200ML, (2MG/ML) IS A MEDICAL COUNTERMEASURE (MCM) REQUIRED  BY THE SNS